Genocea Biosciences (GNCA) Tops Q4 EPS by 3c

Genocea Biosciences (NASDAQ: GNCA) reported Q4 EPS of ($0.37), $0.03 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $221 thousand versus the consensus estimate of $40 thousand.

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• SanDisk upgraded at JPMorgan after investor day; shares climb